MiR-200b plays an inhibitory role in many tumors, including HCC, by targeting DNA methyltransferase 3a, RhoA and BMI1.21,34,35 By bioinformatic analyses and experimental verification, we identified HMGB3 as a target for miR-200b. The gene discussed is HMGB3; the disease is hepatocellular carcinoma.